3 trends in biotech to watch in 2019
Heading into 2019, the biotech industry is in for a reckoning with reality.
As 2019 begins, STAT reporters are taking a look at the stories they’re most eager to track during the year. Find all our “three to watch” series here.
On paper, biotech had quite a year in 2018.
Futuristic medicines demonstrated their worth in clinical trials and now look poised to become revolutionary therapies. Scrappy upstarts developed novel drugs without the need for their pharma forebears. And investors were game to fund the whole endeavor, buying into initial public offerings that kept
